Plasma Deal To Join Grifols And Talecris | June 14, 2010 Issue - Vol. 88 Issue 24 | Chemical & Engineering News
Volume 88 Issue 24 | p. 26 | Concentrates
Issue Date: June 14, 2010

Plasma Deal To Join Grifols And Talecris

Department: Business
Keywords: blood plasma, protein therapeutics

Grifols, a Spanish producer of plasma protein therapies, has agreed to acquire U.S.-based Talecris for about $3.4 billion. Talecris, a former Bayer business that also develops therapies from blood plasma, has been an acquisition candidate since June 2009, when the Federal Trade Commission blocked Australian plasma protein firm CSL from buying it for $3.1 billion. If this deal is approved, it will result in a company with about $2.8 billion in annual sales.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment